当前位置 : 首页 > 市场合作 > 项目信息市场合作
Market cooperation| 发包方名称 | National University Corporation - Okayama |
| 发包方国别(国家/地区) | 日本 |
| 发包方座机 | |
| 发包方传真 | |
| 发包方邮箱 | |
| 发包方地址 | Procurement Section, Management Division, Okayama University Hospital, 2-5-1 Shikata-cho Kita-ku Okayama-shi 700-8558 Japan |
| 发包方网址 | |
| 发包方联系人姓名 | NAKAMOTO Makoto |
| 发包方联系人座机 | 086-235-7540 |
| 发包方联系人手机 | |
| 发包方联系人邮箱 | |
| 项目名称 | A Canakinumab(Genetical Recombination) (150mg1mL 1vial/1case) 30 cases,Ｂ Nivolumab(Genetical Recombination) (240mg24mL 1vial／1case) 590 cases,Ｃ Nusinersen Sodium(12mg5mL 1vial／1case) 3 cases,Ｄ Pembrolizumab(Genetical Recombination) (100mg4mL 1vial／1case) |
| 项目类型 | 其他 - 其他 |
| 项目预算￥ | |
| 项目投标截止时间 | 2021-09-06 |
| 项目开始时间 | |
| 项目结束时间 | |
| 服务商资质要求 | |
| 要求高匹配度成功案例个数 | |
| 项目交付地点 | |
| 是否准许转包或分包 | |
| 项目信息详述 |
⑴ Official in charge of disbursement of the procuring entity : MAKINO Hirofumi, President, Okayama University
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
A Canakinumab(Genetical Recombination) (150mg1mL 1vial/1case) 30 cases
B Nivolumab(Genetical Recombination) (240mg24mL 1vial/1case) 590 cases
C Nusinersen Sodium(12mg5mL 1vial/1case) 3 cases
D Pembrolizumab(Genetical Recombination) (100mg4mL 1vial/1case) 980 cases
E Tisagenlecleucel 10 cases
F Axicabtagene ciloleucel 1 case
⑷ Delivery period : From 1 Octorber, 2021 through 31 March, 2022
⑸ Delivery place : Okayama University Hospital
⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A not come under Article 6 of the Regulation concerning the Contract for Okayama University,
B have the Grade A, Grade B, Grade C or Grade D qualification during fiscal 2021 in the Chugoku area in sales of product for participating in tenders by Single qualification for every ministry and agency,
C prove to have obtained the third-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices,
D prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by the Obligating Officer,
E not be currently under a suspension of business order as instructed by President, Okayama University,
⑺ Time limit of tender : 17 : 00 6 September, 2021
⑻ Contact point for the notice : NAKAMOTO Makoto, Procurement Section, Management Division, Okayama University Hospital, 2-5-1 Shikata-cho Kita-ku Okayama-shi 700-8558 Japan, TEL 086-235-7540
⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.
|
版权所有：天津市数字贸易综合服务平台 备案号：津B2-20080229-9
联系人：高杨 
手机：+86-131-1480-9286 
邮箱：gloria.gao@devott.com 
微信：13114809286 
